Mencoboni, M.; Ceppi, M.; Bruzzone, M.; Taveggia, P.; Cavo, A.; Scordamaglia, F.; Gualco, M.; Filiberti, R.A.
Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis. Cancers 2021, 13, 1388.
https://doi.org/10.3390/cancers13061388
AMA Style
Mencoboni M, Ceppi M, Bruzzone M, Taveggia P, Cavo A, Scordamaglia F, Gualco M, Filiberti RA.
Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis. Cancers. 2021; 13(6):1388.
https://doi.org/10.3390/cancers13061388
Chicago/Turabian Style
Mencoboni, Manlio, Marcello Ceppi, Marco Bruzzone, Paola Taveggia, Alessia Cavo, Francesca Scordamaglia, Marina Gualco, and Rosa Angela Filiberti.
2021. "Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis" Cancers 13, no. 6: 1388.
https://doi.org/10.3390/cancers13061388
APA Style
Mencoboni, M., Ceppi, M., Bruzzone, M., Taveggia, P., Cavo, A., Scordamaglia, F., Gualco, M., & Filiberti, R. A.
(2021). Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis. Cancers, 13(6), 1388.
https://doi.org/10.3390/cancers13061388
